Interferon beta is a medication used to help reduce the frequency of relapses in patients with relapsing-remitting multiple sclerosis (RRMS). It works by modulating the immune system to decrease inflammation and slow the progression of the disease.

Glatiramer acetate is another treatment option for RRMS. It is designed to mimic a protein in the body and helps to prevent the immune system from attacking the nerves, thereby reducing the number of relapses.

Fingolimod is an oral medication that helps to reduce the number of relapses in RRMS by preventing certain immune cells from reaching the brain and spinal cord, which helps to reduce inflammation and nerve damage.

Dimethyl fumarate is a medication taken by mouth that helps to reduce the frequency of relapses in RRMS. It works by activating a pathway in the body that helps protect against inflammation and oxidative stress.

Teriflunomide is an oral medication used to treat RRMS by reducing the number of active immune cells, which helps to decrease inflammation and the frequency of relapses.

Natalizumab is a medication given by infusion that helps to reduce the frequency of relapses in RRMS by preventing immune cells from crossing into the brain and spinal cord, thereby reducing inflammation and nerve damage.

Multiple Sclerosis – Multiple Sclerosis is a chronic disease that affects the central nervous system, particularly the brain and spinal cord. It is characterized by the immune system attacking the protective sheath (myelin) that covers nerve fibers, leading to communication problems between the brain and the rest of the body. Over time, the disease can cause permanent damage or deterioration of the nerves themselves. Symptoms vary widely and can include fatigue, difficulty walking, numbness or tingling, muscle weakness, and problems with coordination and balance. The progression of the disease can be unpredictable, with periods of remission and relapses. In some cases, it may transition to a more progressive form, leading to increased disability.